News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
01
2025
-
12
Exploring Linuo Pharmaceutical’s Digital and Intelligent No. 1 Factory: A Glimpse into the Smart Manufacturing Site of an AI+Computing Power-Driven Injectable Drug Factory
Classification：
行业新闻
Corporate News
Recently, the completion of the AI + Computing Power Intelligent Factory for injectables at Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical has brought the “Digital & Intelligent No. 1 Factory”—the core production workshop—into the public spotlight. This workshop, which integrates intelligence, sterility, and high efficiency, is currently in the stage of debugging and validation, already outlining the future of high-end injectable manufacturing. Today, let’s take a “virtual tour” together and unveil the mysteries of this smart factory!
As soon as you step into Factory No. 1 of Digital Intelligence, the first thing you’ll notice is a strong sense of “order”—the two core production lines are neatly arranged along the planned routes, and the connecting tracks between equipment are clean and well-organized. Workshop staff explained: “Currently, all the core equipment has been installed and the system has been set up. We’re now in the stage of integrated commissioning, but we haven’t yet moved on to formal validation. What we’re doing now is ensuring that the machines, systems, and processes work together seamlessly, so we can be fully prepared for production.”
First Stop: Lyophilized Powder Injection Production Line—Precision Adjustment at the Millimeter Level, Laying the Foundation for Sterile Production
As we approached the lyophilized powder injection production line, the first thing that caught our attention was a piece of equipment with “flexible arms”—this is the production line’s “first checkpoint”: automatic unpacking and bottling. Currently, the system is in the material-handling simulation phase. We saw the automatic unpacking machine repeatedly “practicing its eye coordination” with the aid of a 3D vision system, while the robotic arm was simultaneously calibrating its gripping accuracy.
The bottle-washing and drying stages have successfully implemented the “three waters and four gases” process, and the high-temperature sterilization parameters are gradually being standardized. At the filling and capping station, simultaneous commissioning of filling and online weighing is underway, and the filling accuracy is continuously being optimized toward the target of ±1%. In the capping process, precise positioning combined with servo-driven technology is employed, and the sealing qualification rate is steadily approaching 100%. In the light inspection and leak-testing stage, a 5-megapixel camera is constantly “practicing its eye for detail,” striving to keep the missed-detection rate below three per ten thousand. Meanwhile, in the packaging section, seamless integration has been achieved across the entire process—from labeling and blister-packaging to bundling and boxing—providing a stable and reliable storage environment for the products.
Station Two: BFS Production Line—The “Blow-Fill-Seal” Three-in-One System Takes Its Place, Achieving Both Efficiency and Sterility Standards.
After completing the meticulous commissioning of the freeze-dried powder injection production line, we turned our attention to the BFS production line. This production line, specially designed for plastic ampoule preparations, boasts the key advantage of integrating “bottle blowing, filling, and sealing” into a single, seamless step. Currently, the equipment has undergone basic installation and has now entered the full-process commissioning phase.
The liquid preparation system features flexible switching capabilities, providing “exclusive assurance” for special pharmaceutical products. The sterilization logistics system, powered by intelligent technology, achieves fully automated loading, unloading, and sterilization processes, significantly reducing the need for manual labor. Furthermore, the light inspection and packaging stages are undergoing full-process simulation exercises, laying a solid foundation for efficient subsequent production.
As I walked around the facility, my most profound realization was this: The “tech-savvy” vibe of Factory No. 1 isn’t merely reflected in its cutting-edge equipment—it’s evident in every single adjustment and calibration effort, all centered on “quality.” From continuous operational testing of the Class A laminar flow system, to repeated calibration of filling accuracy, and even to simulated drills of the aseptic process—all these steps are meticulously designed to ensure that, once full-scale production begins, every vial of injectable medicine will meet the highest standards.
The No. 1 Digital and Intelligent Pharmaceutical Plant of Linuo Pharma is not merely a production workshop—it is a modern pharmaceutical model that integrates intelligent manufacturing, green operations, and international standards. Although it has not yet officially begun production, its advanced equipment, intelligent system integration, and rigorous process design have already demonstrated strong production potential and robust quality assurance capabilities.
Lino Pharmaceutical’s Digital Intelligence Factory No. 1 empowers manufacturing with intelligence and seeks resonance through openness. We look forward to exchanging ideas and learning from our upstream and downstream partners, fostering deep collaboration across R&D, production, marketing, and other areas, and jointly pursuing development for mutual benefit and win-win outcomes!
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
2026-05-13
On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.
2026-05-07
On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.
2026-05-07
Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China